Found 22 matching trials
Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules PHASE3 The present study will evaluate the immunogenicity, safety and immunogenici...
Show More Location
Vaccination and Travel Medicine Centre
Learn More & Join Trial
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 PHASE2 This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Show More Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults PHASE2 This trial will assess the immunogenicity and safety of GSK Biologicals' va...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age PHASE2 The purpose of this study is to assess the safety and immunogenicity of dif...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years PHASE3 The purpose of this Phase 3, observer-blind, placebo-controlled, multi-cent...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response PHASE4 The study is a prospective single site exploratory study to examine the imp...
Show More Location
The Hope Clinic of Emory University
Learn More & Join Trial
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects PHASE3 The present study, phase III, randomized, controlled, observer-blind, multi...
Show More Location
Tampere Vaccine Research Clinic (15 sites)
Learn More & Join Trial
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years PHASE2 The purpose of this study is to determine whether GSK's avian flu vaccine G...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above PHASE3 Today, the leading contender for the next pandemic of influenza is H5N1, a ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults PHASE2 Evaluate Safety, Tolerability and Immune Response of Adjuvanted H5N1 Cell C...
Show More Location
1 Miami Research Associates
Learn More & Join Trial